Alzheimer disease & dementia
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Alzheimer disease & dementia

on

  • 650 views

Alzheimer disease & dementia. Prof Nimal Senanayake

Alzheimer disease & dementia. Prof Nimal Senanayake

Statistics

Views

Total Views
650
Views on SlideShare
650
Embed Views
0

Actions

Likes
0
Downloads
9
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Alzheimer disease & dementia Presentation Transcript

  • 1. Alzheimer disease and Dementia Prof. Nimal Senanayake Faculty of medicine University of Peradeniya Sri Lanka
  • 2. Prevalence  Severe dementia in 5% over the age of 65 yr  Mild to moderate in 10-15%  Alzheimer disease: 26.6 million in 2006  Predicted to affect 1 in 85 people globally by 2050
  • 3. Dementia  An acquired condition (DD: Mental retardation/subnormality)  Persistent (DD: Delirium, Acute confusional states)  Must differentiate from Depression, Anxiety etc.
  • 4. Causes of dementia…  Alzheimer disease  Vascular dementia (multi-infarct dementia)  Tumours  Head injuries (Acute/repeated trauma eg. boxers)  Infections (HIV, syphilis…)
  • 5. …Causes of dementia  Thyroid disease (hypo/hyper)  Vitamin B Co deficiency  Toxins, poisons  Normal pressure hydrocephalus  Degenerative diseases (eg. Parkinsonism with dementia, Huntington chorea, Creutzfeldt-Jacob disease, Kuru)
  • 6. Alzheimer disease: Criteria for diagnosis  Onset of dementia age 40-90yr.  Two or more cognitive deficits  Progression over 6 months  Consciousness undisturbed  Absence of other potential causes
  • 7. Cognitive deficits (2/more) in:  Memory  Language  Visuo-spatial skills  Personality/emotional state  Cognition (abstraction, mathematics, judgment)
  • 8. Alzheimer disease   Alois Alzheimer- German psychiatrist and neuropathologist described the first case in 1906 Patient: Auguste Deter
  • 9. Symptomatic progression          Inability to acquire new memories (Loss of recent memory) Confusion Irritability and aggression Mood swings Language breakdown Loss of long-term memory General withdrawal Loss of bodily functions Death
  • 10. Early dementia  Difficulties with language (shrinking vocabulary)  Executive functions  Perception (agnosia)  Execution of movements (apraxia)
  • 11. Moderate dementia …  Wandering  Irritability  Labile affect (crying, outbursts of aggression)  Illusionary misidentifications  Delusional symptoms  Loss of insight  Urinary incontinence
  • 12. Advanced dementia  Language reduced to simple phrases or single words  Leads to complete loss of speech  Can often understand and return emotional signals  Extreme apathy and exhaustion  Unable to perform even the simplest tasks without assistance  Bedridden  Unable to feed themselves  Cause of death an external factor (eg. infection of pressure sores, pneumonia)
  • 13. Prognosis      Individual prognosis difficult to assess, as the duration of the disease varies Develops for an indeterminate period of time before becoming fully apparent Can progress undiagnosed for years Mean life expectancy following diagnosis is approx. 7 years Fewer than 3% live more than 14 years after diagnosis
  • 14. Neuropathology  Characterised by loss of neurons and synapses in the cerebral cortex and certain subcortical regions  Causes gross degeneration esp. temporal lobe, parietal lobe, parts of frontal cortex and cingulate gyrus
  • 15. Brain slices Normal Alzheimer
  • 16. PET scans of brain Normal Alzheimer
  • 17. Microscopy   Amyloid plaques: dense, mostly insoluble deposits of amyloid-beta peptide and cellular material outside and around neurons Neurofibrillary tangles: aggregates of the microtubule-associated protein tau, (hyperphosphorylated) accumulate inside the cells
  • 18. Amyloid plaques
  • 19. Neurofibrillary tangles
  • 20. Mechanism     Cholinergic hypothesis (reduced synthesis of acetylcholine in the brain) Amyloid hypothesis (1991): amyloid beta deposits Tau hypothesis (2004): Tau proteins form neurofibrillary tangles inside nerve cells, microtubules disintegrate, neuron's transport system collapses Myelin hypothesis: Demyelination leads to disruption of axonal transport and loss of neurons
  • 21. Disintegration of microtubules
  • 22. Genetics  Only around 0.1% of the cases are familial  Autosomal-dominant inheritance  Familial cases usually have an onset before age 65
  • 23. Risk factors/Prevention  Cardiovascular risk factors (DM, HT, hypercholesterolaemia)  Diet: fruit, vegetables, bread, wheat and other cereals, olive oil, fish  Moderate use of alcohol esp. red wine  Vitamins: not enough evidence  Coffee: 3–5 cups/day at midlife- 65% reduction  Curry spice turmeic (curcumin) some effectiveness in preventing brain damage in mice
  • 24. Reduced risk  Intellectual activities (eg. reading, playing board games, crossword puzzles)  Playing musical instruments  Regular social interaction  Education  Learning a second language (even later in life)  Physical activity
  • 25. FDA approved medication  Donepezil (AChE inhibitor)  Galantamine (AChE inhibitor)  Rivastigmine (AChE inhibitor)  Memantine (NMDA receptor antagonist)
  • 26. Patient-care  Safety measures  Reduce care-giver burden  Feeding
  • 27. Medical issues  Oral and dental disease  Pressure sores  Malnutrition  Hygiene problems  Respiratory, skin, eye infections